Header Logo

Connection

PAUL SCHURMANN to Humans

Back to Details
This is a "connection" page, showing publications PAUL SCHURMANN has written about Humans.
PAUL SCHURMANN
Connection Strength
0.200
Humans
  1. Mechanisms of Mitral Isthmus Reconnection After Ablation With and Without Vein of Marshall Ethanol Infusion. JACC Clin Electrophysiol. 2024 Nov; 10(11):2420-2430.
    View in: PubMed
    Score: 0.025
  2. Arrhythmias in COVID-19. Methodist Debakey Cardiovasc J. 2021; 17(5):73-82.
    View in: PubMed
    Score: 0.021
  3. Device Therapy for Sudden Cardiac Death Prophylaxis After Acute Coronary Syndrome: When and Why? Curr Cardiol Rep. 2020 01 16; 22(1):4.
    View in: PubMed
    Score: 0.018
  4. Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation. Heart Rhythm. 2016 Feb; 13(2):593-601.
    View in: PubMed
    Score: 0.014
  5. Ethanol for the treatment of cardiac arrhythmias. Curr Opin Cardiol. 2015 Jul; 30(4):333-43.
    View in: PubMed
    Score: 0.013
  6. Organoid modeling reveals the tumorigenic potential of the alveolar progenitor cell state. EMBO J. 2025 Mar; 44(6):1804-1828.
    View in: PubMed
    Score: 0.006
  7. Validation of Noninvasive Left Atrial Stiffness Against Left Atrial Operating Chamber Stiffness by Cardiac Catheterization. JACC Cardiovasc Imaging. 2024 Aug; 17(8):1000-1002.
    View in: PubMed
    Score: 0.006
  8. Ventricular arrhythmias prior to continuous flow left ventricular assist device implantation were not associated with reduced 1-year mortality: a single-center experience. J Interv Card Electrophysiol. 2024 Jun; 67(4):705-707.
    View in: PubMed
    Score: 0.006
  9. Stellate ganglion instrumentation for pharmacological blockade, nerve recording, and stimulation in patients with ventricular arrhythmias: Preliminary experience. Heart Rhythm. 2023 06; 20(6):797-805.
    View in: PubMed
    Score: 0.006
  10. Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease. Circulation. 2022 11 29; 146(22):1644-1656.
    View in: PubMed
    Score: 0.006
  11. Acute and Long-Term Scar Characterization of Venous Ethanol Ablation in the Left Ventricular Summit. JACC Clin Electrophysiol. 2023 01; 9(1):28-39.
    View in: PubMed
    Score: 0.006
  12. Advanced Techniques for Ethanol Ablation of Left Ventricular Summit Region Arrhythmias. Circ Arrhythm Electrophysiol. 2022 08; 15(8):e011017.
    View in: PubMed
    Score: 0.005
  13. Venous anatomy of the left ventricular summit: Therapeutic implications for ethanol infusion. Heart Rhythm. 2021 09; 18(9):1557-1565.
    View in: PubMed
    Score: 0.005
  14. Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure. Catheter Cardiovasc Interv. 2021 11 15; 98(6):E839-E846.
    View in: PubMed
    Score: 0.005
  15. Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021 07; 18(7):1045-1054.
    View in: PubMed
    Score: 0.005
  16. Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial. JAMA. 2020 10 27; 324(16):1620-1628.
    View in: PubMed
    Score: 0.005
  17. Left atrial appendage occlusion using intracardiac echocardiography. Heart Rhythm. 2021 02; 18(2):313-317.
    View in: PubMed
    Score: 0.005
  18. Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience. JACC Clin Electrophysiol. 2020 10 26; 6(11):1420-1431.
    View in: PubMed
    Score: 0.005
  19. Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins. Heart Rhythm. 2020 12; 17(12):2126-2134.
    View in: PubMed
    Score: 0.005
  20. Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: Procedural and cost considerations. Heart Rhythm. 2019 03; 16(3):334-342.
    View in: PubMed
    Score: 0.004
  21. Loperamide Mimicking Brugada Pattern. Methodist Debakey Cardiovasc J. 2018 Oct-Dec; 14(4):e1-e3.
    View in: PubMed
    Score: 0.004
  22. In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF. Ann Intern Med. 2018 05 15; 168(10):JC55.
    View in: PubMed
    Score: 0.004
  23. The Human Left Atrial Venous Circulation?as a Vascular Route for Atrial?Pharmacological Therapies: Effects of Ethanol Infusion. JACC Clin Electrophysiol. 2017 09; 3(9):1020-1032.
    View in: PubMed
    Score: 0.004
  24. Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature. JACC Clin Electrophysiol. 2017 03; 3(3):253-265.
    View in: PubMed
    Score: 0.004
  25. Position-Dependent Ventricular Tachycardia Related to Peripherally Inserted Central Venous Catheter. Methodist Debakey Cardiovasc J. 2016 Sep; 12(3):177-178.
    View in: PubMed
    Score: 0.004
  26. Retrograde Coronary Venous Ethanol Infusion for Ablation of Refractory Ventricular Tachycardia. Circ Arrhythm Electrophysiol. 2016 07; 9(7).
    View in: PubMed
    Score: 0.004
  27. Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia. Heart Rhythm. 2016 06; 13(6):1238-1245.
    View in: PubMed
    Score: 0.003
  28. Left Atrial Appendage Remodeling After Lariat Left Atrial Appendage Ligation. Circ Arrhythm Electrophysiol. 2015 Dec; 8(6):1351-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.